Qingbei Zeng - Concepedia

Author

Qingbei Zeng

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Qingbei Zeng

Publications

673

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)The Ohio State University WuXi AppTec (China)United States Military Academy Ligand Pharmaceuticals (United States)

About

Qingbei Zeng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	489
2	Natural Sciences	11	11	207
3	Biochemistry	11	12	259
4	Biomolecular Engineering	7	7	127
5	Engineering	6	6	89

Qingbei Zeng

Publications

618

Citations

H-Index

Page 1

	Year	Citations
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Qingbei Zeng, Jiabing Wang, Ziqiang Cheng, Journal of Medicinal Chemistry PathologyPharmacotherapyGliomaMedicinal ChemistryCentral Nervous System-penetrant	2015	148
I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles G. Anilkumar, Charles A. Lesburg, Oleg Selyutin, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineIndole 2-Carboxylic AcidsAntiviral Drug DevelopmentAntiviral Drug	2011	49
Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase Kevin X. Chen, Bancha Vibulbhan, Weiying Yang, Journal of Medicinal Chemistry Structure–activity RelationshipPharmaceutical ScienceViral Polymerase StructureHepatitis C VirusIndole Core	2011	30
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development Anilkumar G. Nair, Qingbei Zeng, Oleg Selyutin, Bioorganic & Medicinal Chemistry Letters Sar DevelopmentSilyl ProlineMedicineImmunologyAntiviral Drug Development	2016	27
A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors Kevin X. Chen, Charles A. Lesburg, Bancha Vibulbhan, Journal of Medicinal Chemistry Pharmaceutical ScienceMolecular BiologyAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	2012	27
II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists Yuefei Shao, G. Anilkumar, Carolyn DiIanni Carroll, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyCxcr3 Chemokine AntagonistsDerivativesMedicinePharmacological Agent	2010	23
II. Novel HCV NS5B polymerase inhibitors: Discovery of indole C2 acyl sulfonamides G. Anilkumar, Oleg Selyutin, Stuart B. Rosenblum, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineAntiviral Drug Development	2011	22
Base-promoted 1,2-shifts in α-benzyloxy ketones Leo A. Paquette, Qingbei Zeng Tetrahedron Letters Organic ChemistryEnantioselective SynthesisBase-promoted 1,2-ShiftsChemistry	1999	22
Reactions of Arylmethanethiols with 1,4-Disubstituted 1,3-Butadiynes Fillmore Freeman, Hengyao Lu, Qingbei Zeng, The Journal of Organic Chemistry Molecular SciencesHeterocyclicChemical MeasurementChemical AnalysisDonut Icon	1994	22
IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles Anilkumar G. Nair, Michael Wong, Youheng Shu, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryMetabolic ProfilesBiochemistryMedicine	2014	19

Page 1